Table 2 Prevalence of the metabolic syndrome and components among all study participants and by sex
Syndrome & components | Male (n = 378) | Female (n = 461) | Total (N = 839) | |||
|---|---|---|---|---|---|---|
| Â | % (95%CI) | % (95%CI) | % (95%CI) | |||
Occurrence of the Metabolic Syndrome and combinations of its components | ||||||
Metabolic Syndrome (≥ 3 components) | 0.5 | (0.2-1.3) | 1.7 | (0.5-2.9) | 1.2 | (0.5-1.9) |
≥ 2 Metabolic Syndrome Components*** | 8.5 | (5.7-11.3) | 21.3 | (17.5-25.0) | 15.5 | (13.0-17.9) |
≥ 1 Metabolic Syndrome Components*** | 38.6 | (33.7-43.5) | 67.5 | (63.2-71.7) | 54.4 | (51.1-57.8) |
Individual Components | ||||||
WC*** | 5.3 | (3.0-7.5) | 24.7 | (20.8-28.6) | 16.0 | (13.5-18.5) |
High BP*** | 10.8 | (7.7-14.0) | 3.3 | (1.6-4.9) | 6.7 | (5.0-8.4) |
IFG*** | 2.1 | (0.6-3.6) | 0.4 | (0-1.0) | 1.2 | (0.4-1.9) |
Low HDL*** | 28.8 | (24.3-33.4 | 61.6 | (57.2-66.0) | 46.8 | (43.5-50.2) |
High Triglycerides | 0.5 | (0-1.2) | 0.6 | (0-1.3) | 0.6 | (0.1-1.1) |